(Q44428968)

2 December 2017

title

5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo (English)

1 reference

2 December 2017

1 reference

0 references

1 reference

10

1 reference

2 December 2017

Andreas Broocks

1

1 reference

2 December 2017

T Meyer

2

1 reference

2 December 2017

M Opitz

3

1 reference

2 December 2017

U Bartmann

4

1 reference

2 December 2017

U Hillmer-Vogel

5

1 reference

2 December 2017

A George

6

1 reference

2 December 2017

G Pekrun

7

1 reference

2 December 2017

D Wedekind

8

1 reference

2 December 2017

E Rüther

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

European Neuropsychopharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

13

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

153-164

1 reference

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Behavioral treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

1 reference

7 January 2021

Attenuated response to m-CPP and to pentagastrin after repeated m-CPP in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—II. Effects of acute administration of 1-PP and long-term adminstration of tandospirone on noradrenergic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Current advances and trends in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Changes in plasma concentrations of aromatic and branched-chain amino acids during sustained exercise in man and their possible role in fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effects of exercise training on older patients with major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Cardiovascular and behavioral effects of aerobic exercise training in healthy older men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Aerobic exercise reduces levels of cardiovascular and sympathoadrenal responses to mental stress in subjects without prior evidence of myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

The influence of semistarvation-induced hyperactivity on hypothalamic serotonin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effects of acute physical exercise on central serotonergic systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Physical exercise: evidence for differential consequences of tryptophan on 5-HT synthesis and metabolism in central serotonergic cell bodies and terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Motor activity increases tryptophan, 5-hydroxyindoleacetic acid, and homovanillic acid in ventricular cerebrospinal fluid of the conscious rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effects of carbohydrate feedings on plasma free tryptophan and branched-chain amino acids during prolonged cycling

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Exercise and mental health

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Measurement of lactate-induced panic and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Increased cardiac awareness in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Heartbeat perception and panic disorder: possible explanations for discrepant findings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Brain serotonin content: physiological dependence on plasma tryptophan levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Exercise changes in plasma tryptophan fractions and relationship with prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Running as treatment for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Psychological effects of habitual aerobic exercise: A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effects of ipsapirone in healthy subjects: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

m-Chlorophenylpiperazine as a probe of serotonin function

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

The effect of exercise on normal mood.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

5-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine Blunted Temperature and Hormone Responses to Ipsapirone Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

5-HT1A receptor-effector system responsivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Lactate provocation of panic attacks. I. Clinical and behavioral findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Lactate provocation of panic attacks. II. Biochemical and physiological findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

The psychological benefits of exercise and the treatment of delinquent adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Involvement of 5-HT1A and 5-HT1B receptors for citalopram-induced hypothermia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Carbon dioxide hypersensitivity, hyperventilation, and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Reducing symptoms of depression with exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Lactate Metabolism in Anxiety Neurosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Respiratory control in the treatment of panic attacks: replication and extension with concurrent measurement of behaviour and pCO2.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effect of paroxetine and nefazodone on 5-HT 1A receptor sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Exercise intensity and reduction in neurotic symptoms. A controlled follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Sympathetic nervous system and behavioral responses to stress following exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effect of exercise intensity on free tryptophan to branched-chain amino acids ratio and plasma prolactin during endurance exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effect of acute and chronic exercise on plasma amino acids and prolactin concentrations and on [3H]ketanserin binding to serotonin2A receptors on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Control of brain neurotransmitter synthesis by precursor availability and nutritional state

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Running versus weight lifting in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

Influence of aerobic exercise on depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900177-3

7 January 2021

10.1016/S0924-977X(02)00177-3

Identifiers

DOI

1 reference

release_pkjpgmyyuzg7pnsgzr6xvmvidq

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pkjpgmyyuzg7pnsgzr6xvmvidq

24 November 2022

mapped directly with Wikidata item

1 reference